NCS Multistage (NASDAQ:NCSM - Get Free Report) will likely be posting its quarterly earnings results before the market opens on Wednesday, March 5th. Analysts expect NCS Multistage to post earnings of $0.83 per share and revenue of $40.60 million for the quarter. Individual that wish to register for the company's earnings conference call can do so using this link.
NCS Multistage Stock Down 3.8 %
NASDAQ:NCSM traded down $1.06 during trading hours on Friday, reaching $26.93. 2,086 shares of the company traded hands, compared to its average volume of 6,146. The business's 50-day moving average price is $28.18 and its two-hundred day moving average price is $23.55. The stock has a market capitalization of $67.41 million, a P/E ratio of 1.58 and a beta of 1.16. NCS Multistage has a 1 year low of $14.75 and a 1 year high of $31.82. The company has a current ratio of 4.50, a quick ratio of 2.63 and a debt-to-equity ratio of 0.06.
NCS Multistage Company Profile
(
Get Free Report)
NCS Multistage Holdings, Inc provides engineered products and support services for oil and natural gas well completions and construction, and field development strategies in the United States, Canada, and internationally. It offers fracturing systems, which include casing-installed sliding sleeves, downhole frac isolation assemblies, and sand jet perforating products; enhanced recovery products, such as sliding sleeve, as well as Terrus system, an injection control device; repeat precision products comprising composite frac plugs and bridge plugs, single-use disposable setting tools, express systems, and related products; chemical and radioactive tracer diagnostics services; and well construction products, including AirLock casing buoyancy system, Vecturon and Vectraset liner hanger systems, and Toe initiation sleeves.
See Also

Before you consider NCS Multistage, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NCS Multistage wasn't on the list.
While NCS Multistage currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.